128 related articles for article (PubMed ID: 21409916)
1. Efficacy of amikacin and ciprofloxacin against clinical isolates of Mycobacterium tuberculosis.
Satti M; Faqir F; Sattar A; Abbasi S; Butt T; Karamat KA; Abidi M
J Ayub Med Coll Abbottabad; 2010; 22(1):101-3. PubMed ID: 21409916
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
Abate G; Miörner H; Ahmed O; Hoffner SE
Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
[TBL] [Abstract][Full Text] [Related]
4. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Bhusal Y; Shiohira CM; Yamane N
Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance to the first line of antitubercular regimen (a preliminary report).
Varaiya A; Gogate A
Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
[TBL] [Abstract][Full Text] [Related]
6. Drug-resistant tuberculosis in Egyptian children using Etest.
Morcos W; Morcos M; Doss S; Naguib M; Eissa S
Minerva Pediatr; 2008 Dec; 60(6):1385-92. PubMed ID: 18971899
[TBL] [Abstract][Full Text] [Related]
7. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
[TBL] [Abstract][Full Text] [Related]
8. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
9. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.
Prammananan T; Arjratanakool W; Chaiprasert A; Tingtoy N; Leechawengwong M; Asawapokee N; Leelarasamee A; Dhiraputra C
Int J Tuberc Lung Dis; 2005 Feb; 9(2):216-9. PubMed ID: 15732744
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic mass caused by Mycobacterium tuberculosis with reduced drug sensitivity.
Small G; Wilks D
J Infect; 2001 Apr; 42(3):201-2. PubMed ID: 11545552
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.
Krüüner A; Yates MD; Drobniewski FA
J Clin Microbiol; 2006 Mar; 44(3):811-8. PubMed ID: 16517859
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia.
Kordy FN; Al-Thawadi S; Alrajhi AA
Int J Tuberc Lung Dis; 2004 Aug; 8(8):1007-11. PubMed ID: 15305485
[TBL] [Abstract][Full Text] [Related]
14. [The role of bacteriology in the treatment of tuberculosis; the Hungarian program].
Fodor T
Orv Hetil; 2000 Sep; 141(36):1981-3. PubMed ID: 11031835
[TBL] [Abstract][Full Text] [Related]
15. Study on Mycobacterium tuberculosis: the primary drug resistance pattern.
Siddique MA; Rahman KM; Muazzam N; Hossain T; Islam KM; Rahman MA; Chowdhury FA; Ali CM
Bangladesh Med Res Counc Bull; 1995 Apr; 21(1):18-23. PubMed ID: 7575339
[TBL] [Abstract][Full Text] [Related]
16. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
17. [Incidence of tuberculostatic-resistant Mycobacterium tuberculosis. Clinical aspects and impact on therapy and clinical course].
Esteban J; Gegúndez MI; García-Corbeira P; Soriano F
Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):415-9. PubMed ID: 8260512
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
[TBL] [Abstract][Full Text] [Related]
19. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
[TBL] [Abstract][Full Text] [Related]
20. Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
Sugawara I; Zhang J; Li C
Indian J Exp Biol; 2009 Jun; 47(6):520-2. PubMed ID: 19634718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
